• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据体外释放动力学预测体内血浆浓度:在犬类亲脂性载体中多塞平注射用(肌肉注射)混悬液的应用。

Predictions of in vivo plasma concentrations from in vitro release kinetics: application to doxepin parenteral (i.m.) suspensions in lipophilic vehicles in dogs.

作者信息

Gido C, Langguth P, Mutschler E

机构信息

Department of Pharmacology, Johann Wolfgang Goethe-University, Frankfurt/Main, Germany.

出版信息

Pharm Res. 1994 Jun;11(6):800-8. doi: 10.1023/a:1018913321164.

DOI:10.1023/a:1018913321164
PMID:7937517
Abstract

A flow through dissolution system was applied to obtain biorelevant dissolution rates from controlled release systems for parenteral administration using the antidepressant doxepin as a model compound. Plasma concentrations were simulated using the disposition function of doxepin obtained from administration of an aqueous doxepin solution (AponalR) to beagle dogs. Input functions were obtained from in vitro dissolution experiments with three parenteral controlled release suspensions of doxepin hydrochloride (DHCl), doxepin pamoate (DP-1), and microspheres of doxepin hydrochloride in poly D,L-lactid-co-glycolid (MC-1) in isopropyl myristate. The predicted plasma concentrations were compared with experimentally obtained concentrations in vivo. Good correlations (r > 0.88) between observed and predicted data were obtained for all formulations investigated. Similarly, in vivo release kinetics calculated by the Loo-Riegelman method were compard with release kinetics measured in vitro and showed good correlations (r > 0.89). It is anticipated that the in vitro dissolution system permits assessment of the clinical relevance of observed variations in dissolution rates e.g. between batches of one formulation.

摘要

采用流通式溶解系统,以抗抑郁药多塞平作为模型化合物,从用于肠胃外给药的控释系统中获取生物相关溶解速率。利用给比格犬静脉注射多塞平水溶液(阿普诺尔R)后得到的多塞平处置函数来模拟血浆浓度。输入函数通过在肉豆蔻酸异丙酯中对三种肠胃外控释悬浮液进行体外溶解实验获得,这三种悬浮液分别为盐酸多塞平(DHCl)、双羟萘酸多塞平(DP - 1)以及聚D,L - 丙交酯 - 乙交酯中的盐酸多塞平微球(MC - 1)。将预测的血浆浓度与体内实验获得的浓度进行比较。对于所有研究的制剂,观察到的数据与预测数据之间均具有良好的相关性(r > 0.88)。同样,通过Loo - Riegelman方法计算的体内释放动力学与体外测量的释放动力学进行比较,显示出良好的相关性(r > 0.89)。预计体外溶解系统能够评估观察到的溶解速率变化(例如同一制剂不同批次之间)的临床相关性。

相似文献

1
Predictions of in vivo plasma concentrations from in vitro release kinetics: application to doxepin parenteral (i.m.) suspensions in lipophilic vehicles in dogs.根据体外释放动力学预测体内血浆浓度:在犬类亲脂性载体中多塞平注射用(肌肉注射)混悬液的应用。
Pharm Res. 1994 Jun;11(6):800-8. doi: 10.1023/a:1018913321164.
2
Conventional versus novel conditions for the in vitro dissolution testing of parenteral slow release formulations: application to doxepin parenteral dosage forms.
Pharmazie. 1993 Oct;48(10):764-9.
3
Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.开发一种用于设计缓释口服剂型的具有生理相关性的群体药代动力学体外-体内相关性方法。
Mol Pharm. 2017 Jan 3;14(1):53-65. doi: 10.1021/acs.molpharmaceut.6b00677. Epub 2016 Dec 12.
4
In vitro evaluation of the dissolution rate of crystalline suspensions destined to intramuscular administration.用于肌肉注射的结晶混悬液溶出速率的体外评价。
Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:379-84.
5
In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.体外溶解度、溶出度和渗透性研究结合半机理模型,以研究右美沙芬从速释和缓释制剂中的肠道吸收情况。
Eur J Pharm Sci. 2015 Sep 18;77:303-13. doi: 10.1016/j.ejps.2015.06.012. Epub 2015 Jun 16.
6
Bioavailability investigation of two different oral formulations of doxepin.多塞平两种不同口服制剂的生物利用度研究。
Arzneimittelforschung. 2001;51(3):189-96. doi: 10.1055/s-0031-1300024.
7
Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.双氯芬酸钠口服缓释制剂在比格犬体内外的比较评价
Pharmazie. 2009 Oct;64(10):648-52.
8
Transbuccal delivery of doxepin: studies on permeation and histological investigation.多塞平的经颊给药:渗透研究与组织学调查
Int J Pharm. 2014 Dec 30;477(1-2):650-4. doi: 10.1016/j.ijpharm.2014.10.060. Epub 2014 Nov 1.
9
A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets.一种用于预测口服缓释骨架片体内性能的犬生物相关溶出方法。
Drug Dev Ind Pharm. 2016;42(5):836-44. doi: 10.3109/03639045.2015.1082583. Epub 2015 Sep 4.
10
Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs.基于多孔硅纳米粒子的难溶性药物水飞蓟宾 72 小时释放制剂:在比格犬体内外的释放动力学和相关性研究。
Eur J Pharm Sci. 2013 Jan 23;48(1-2):64-71. doi: 10.1016/j.ejps.2012.10.012. Epub 2012 Nov 2.

本文引用的文献

1
Conventional versus novel conditions for the in vitro dissolution testing of parenteral slow release formulations: application to doxepin parenteral dosage forms.
Pharmazie. 1993 Oct;48(10):764-9.
2
Studies on the absorption of practically water-insoluble drugs following injection. IV. An approach for predicting relative intramuscular absorption rates of a drug in oily solution, aqueous suspension and aqueous surfactant solution in rats.注射后几乎不溶于水的药物的吸收研究。IV. 预测大鼠油性溶液、水混悬液和水性表面活性剂溶液中药物相对肌肉注射吸收速率的方法。
Chem Pharm Bull (Tokyo). 1981 May;29(5):1410-5. doi: 10.1248/cpb.29.1410.
3
Protein binding of doxepin and desmethyldoxepin.多塞平与去甲多塞平的蛋白质结合情况。
Acta Pharmacol Toxicol (Copenh). 1982 Aug;51(2):159-64. doi: 10.1111/j.1600-0773.1982.tb01008.x.
4
Doxepin plasma concentrations in clinical practice. Could there be a pharmacokinetic explanation for low concentrations?临床实践中多塞平的血浆浓度。低浓度是否存在药代动力学方面的解释?
Clin Pharmacokinet. 1985 Jul-Aug;10(4):365-70. doi: 10.2165/00003088-198510040-00006.
5
High-performance liquid chromatographic determination of trans-doxepin and desmethyldoxepin.反式多塞平和去甲多塞平的高效液相色谱测定法
Arzneimittelforschung. 1988 Oct;38(10):1525-8.
6
Pharmacological evaluation of an injectable prolonged release emulsion of physostigmine in rabbits.毒扁豆碱注射用长效乳剂在兔体内的药理学评价
J Pharm Pharmacol. 1986 Sep;38(9):653-8. doi: 10.1111/j.2042-7158.1986.tb03104.x.
7
Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.可生物降解的聚乳酸和聚丙交酯-乙交酯微胶囊:与制备技术和释放特性相关的问题
J Microencapsul. 1990 Jul-Sep;7(3):297-325. doi: 10.3109/02652049009021842.
8
Stereoselective pharmacokinetics of doxepin isomers.
Eur J Clin Pharmacol. 1992;42(5):539-44. doi: 10.1007/BF00314865.
9
Dosage schedule and plasma levels of doxepin and desmethyldoxepin.
J Clin Psychiatry. 1978 Oct;39(10):740-2.
10
Doxepin kinetics.
Clin Pharmacol Ther. 1978 May;23(5):573-9. doi: 10.1002/cpt1978235573.